Liftstream is an executive search recruitment company in the life sciences sector
eFFECTOR Therapeutics Secures New Series B Funding
eFFECTOR Therapeutics, an early-stage company focused on the discovery and development of small molecule cancer therapeutics in San Diego, has secured its Series B financing up to USD 56 million. The new funding came from Sectoral Asset Management, a new investor in the syndicate, as well as existing investors. Meanwhile, eFFECTOR Therapeutics appointed Maha Katabi, a partner from Sectoral, to its board of directors.
Wilson Therapeutics Raises $40m to advance development program
Authored by James Sheppard
Posted in Executive Appointments, Orphan Drugs and Rare Diseases, Pharmaceutical business
Tagged Abingworth LLP, biotech, Board of Directors, CEO, Chairman, Dr Bali Muralidhar, Dr Genghis Lloyd Harris, Dr Hugh Reinhoff, Dr Marteen Steen, EMA, FDA, HealCap, Imago Bioscience, Investment, Jonas Hansson, Medicon Valley, Mr Jacob Gunterberg, MVM Life Science Partners LLP, orphan drug designation, Series B funding, venture capital, Wilson Therapeutics, Wilson's Disease, WTX101
Leave a comment
Merus Biopharmaceuticals building to future with strong pipeline
Authored by James Sheppard
Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business
Tagged Acute Myeloid Leukaemia, Affitech, Aglaia Biomedical Ventures, Amsterdam Biotech, Astellas, Bay City Capital, bispecific, Charity, Crucell, Dr Setareh van Driel Shamsili, European Society of Hematology, funding, government, hematology, IND, Johnson & Johnson, Life Science Partners, London Biotech, London Innovation Centre, MCLA-117, Merus Biopharmaceuticals, Mr Jason Avery, Netherlands, Novartis Venture Fund, oncology, Pfizer, Series B funding, Ton Logtenberg
Leave a comment